サマリー

世界の特殊PACS市場は、2020年に26億8,288万ドルで、2021年から2030年までCAGR5.5%を記録し、2030年には44億8,596万ドルに達すると予測されています。
PACS（Picture Archiving and Communication System）は、主に医療機関で使用される医療画像技術で、電子画像や臨床関連の報告書を安全に保存し、デジタル送信するためのものです。PACSを使用することにより、機密性の高い情報、フィルム、報告書を手作業でファイリング、保管、検索、送信する必要がなくなります。また、医療文書や画像はオフサイトサーバーに安全に保管され、PACSソフトウェア、ワークステーション、モバイルデバイスを使用して、基本的に世界のどこからでも安全にアクセスすることが可能です。PACSのような医療画像ストレージ技術は、医療業界全体でデジタル医療画像の量が増加し、これらの画像のデータ分析がより一般的になるにつれて、ますます重要性を増しています。PACSは、ハードウェアの画像処理装置、患者画像の配信と交換のための安全なネットワーク、画像を閲覧・処理・解釈するためのワークステーションやモバイル機器、画像や関連文書・報告書を保存・検索するための電子アーカイブの4つの主要部分から構成されています。PACSは、ハードコピーフィルムの代替や物理的なアーカイブの管理など、さまざまな用途に使用されています。また、リモートアクセスも可能で、異なる場所にいる臨床医が同じデータを同時に確認することができます。
高齢者人口の増加と医療画像処理量の増加が、特殊PACS市場の成長を促進する主な要因となっています。また、慢性疾患の増加、医療画像への投資の増加、画像機器の使用量の増加、医療画像ヘルスケアITソリューションの採用の増加、特殊PACSの進歩、ヘルスケアITソリューションの採用を促進する政府の取り組みの増加、病気の早期診断に関する意識の高まりなども、市場の成長を後押しする要因となっています。しかし、技術に対する人々の認識不足、治療費の増加、特殊PACSの開発の遅れ、政府の取り組みの少なさなどが市場成長の妨げになると予想されます。さらに、外来センターの増加、研究開発の進歩、製品や治療のコスト削減、病院施設の増加、イメージングソリューションの進歩は、市場成長のための有利な機会を提供します。
特殊PACS市場は、タイプ、展開モデル、エンドユーザー、地域に区分されます。タイプ別では、放射線科PACS、整形外科PACS、腫瘍科PACS、病理学PACS、眼科PACS、女性健康PACS、その他に分類されます。導入モデル別では、オンプレミス型専門PACSとクラウド型専門PACSに分類される。エンドユーザー別では、病院・診療所、外来手術センター、その他に分類されます。地域別では、北米、欧州、アジア太平洋、LAMEAで分析されています。

ステークホルダーにとっての主なメリット

本レポートは、現在の市場動向と2020年から2030年までの将来予測を詳細に定量分析し、有力な市場機会の特定を支援するものです。
様々な地域の詳細な分析により、現在の動向を詳細に把握し、ステークホルダーが地域別の計画を策定できるようにすることが期待されます。
特殊PACS市場の成長を促進し、抑制する要因の包括的な分析が提供されます。
様々な地域の広範な分析は、企業が戦略的にビジネスの動きを計画することを可能にする洞察を提供します。
主要市場セグメント
#タイプ別
## 放射線科PACS
##整形外科PACS
##腫瘍学PACS
##病理学PACS
##眼科PACS
#ウィメンズヘルスPACS
##その他
#展開モデル別
##オンプレミス型スペシャリティPACS
##クラウド型スペシャリティPACS
#エンドユーザー別
##病院・クリニック
##外来手術センター
##その他
#地域別
##北米
###米国
###カナダ
###メキシコ
##ヨーロッパ
###ドイツ
###フランス
###イギリス
###イタリア
###スペイン
###その他のヨーロッパ
##アジア太平洋地域
###日本
###中国
###オーストラリア
###インド
###韓国
###その他のアジア太平洋地域
#ラメア
###ブラジル
###サウジアラビア
###南アフリカ
###LAMEAの残りの地域

主要な市場関係者
- キヤノン株式会社(キヤノンメディカルシステム株式会社)
- INC エスカロンメディカル株式会社
- アイパックス合同会社
- IBM株式会社
- INFINITTヘルスケア株式会社株式会社エヌ・ティ・ティ・ドコモ
- フィリップスN.V.
- マッケソンコーポレーション
- ノバラッド
- オネックス社（ケアストリームヘルス社）
- シーメンスAG

ページTOPに戻る

目次

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in investments in medical imaging
3.5.1.2.Rise in use of imaging equipment
3.5.1.3.Surge in geriatric population

3.5.2.Restraint

3.5.2.1.Low awareness regarding the technology
3.5.2.2.Increase in cost of treatment

3.5.3.Opportunity

3.5.3.1.Advancements in imaging solution

3.5.4.Impact analysis

3.6.COVID-19 Impact Analysis on Specialty PACS Market

CHAPTER 4:SPECIALTY PACS MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Radiology PACS

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Orthopedics PACS

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country

4.4.Oncology PACS

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country

4.5.Pathology PACS

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast
4.5.3.Market analysis, by country

4.6.Ophthalmology PACS

4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast
4.6.3.Market analysis, by country

4.7.Women’s health PACS

4.7.1.Key market trends, growth factors, and opportunities
4.7.2.Market size and forecast
4.7.3.Market analysis, by country

4.8.Others

4.8.1.Key market trends, growth factors, and opportunities
4.8.2.Market size and forecast
4.8.3.Market analysis, by country

CHAPTER 5:SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL

5.1.Overview

5.1.1.Market size and forecast

5.2.On-Premises Specialty PACS

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Cloud-based Specialty PACS

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

CHAPTER 6:SPECIALTY PACS MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Hospitals & clinics

6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country

6.3.Ambulatory Surgical Centers

6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country

6.4.Others

6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country

CHAPTER 7:SPECIALTY PACS MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America market size & forecast, by country

7.2.2.1.U.S.

7.2.2.1.1.U.S. Specialty PACS market, by type
7.2.2.1.2.U.S. Specialty PACS market, By Deployment model
7.2.2.1.3.U.S. Specialty PACS market, by end user

7.2.2.2.Canada

7.2.2.2.1.Canada Specialty PACS market, by type
7.2.2.2.2.Canada Specialty PACS market, By Deployment model
7.2.2.2.3.Canada Specialty PACS market, by end user

7.2.2.3.Mexico

7.2.2.3.1.Mexico Specialty PACS market, by type
7.2.2.3.2.Mexico Specialty PACS market, By Deployment model
7.2.2.3.3.Mexico Specialty PACS market, by end user

7.2.3.North America market size and forecast, by type
7.2.4.North America market size and forecast, By Deployment model
7.2.5.North America market size and forecast, by end user

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country

7.3.2.1.Germany

7.3.2.1.1.Germany Specialty PACS market, by type
7.3.2.1.2.Germany Specialty PACS market, By Deployment model
7.3.2.1.3.Germany Specialty PACS market, by end user

7.3.2.2.France

7.3.2.2.1.France Specialty PACS market, by type
7.3.2.2.2.France Specialty PACS market, By Deployment model
7.3.2.2.3.France Specialty PACS market, by End User

7.3.2.3.UK

7.3.2.3.1.UK Specialty PACS market, by type
7.3.2.3.2.UK Specialty PACS market, By Deployment model
7.3.2.3.3.UK Specialty PACS market, by end user

7.3.2.4.Italy

7.3.2.4.1.Italy Specialty PACS market, by type
7.3.2.4.2.Italy Specialty PACS market, By Deployment model
7.3.2.4.3.Italy Specialty PACS market, by end user

7.3.2.5.Spain

7.3.2.5.1.Spain Specialty PACS market, by type
7.3.2.5.2.Spain Specialty PACS market, By Deployment model
7.3.2.5.3.Spain Specialty PACS market, by end user

7.3.2.6.Rest of Europe

7.3.2.6.1.Rest of Europe Specialty PACS market, by type
7.3.2.6.2.Rest of Europe Specialty PACS market, By Deployment model
7.3.2.6.3.Rest of Europe Specialty PACS market, by end user

7.3.3.Europe market size and forecast, by type
7.3.4.Europe market size and forecast, By deployment model
7.3.5.Europe market size and forecast, by End User

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country

7.4.2.1.Japan

7.4.2.1.1.Japan Specialty PACS market, by type
7.4.2.1.2.Japan Specialty PACS market, By Deployment model
7.4.2.1.3.Japan Specialty PACS market, by end user

7.4.2.2.China

7.4.2.2.1.China Specialty PACS market, by type
7.4.2.2.2.China Specialty PACS market, By Deployment model
7.4.2.2.3.China Specialty PACS market, by end user

7.4.2.3.Australia

7.4.2.3.1.Australia Specialty PACS market, by type
7.4.2.3.2.Australia Specialty PACS market, By Deployment model
7.4.2.3.3.Australia Specialty PACS market, by end user
7.4.2.3.4.India Specialty PACS market, by type
7.4.2.3.5.India Specialty PACS market, By Deployment model
7.4.2.3.6.India Specialty PACS market, by end user

7.4.2.4.South Korea

7.4.2.4.1.South Korea Specialty PACS market, by type
7.4.2.4.2.South Korea Specialty PACS market, By Deployment model
7.4.2.4.3.South Korea Specialty PACS market, by end user

7.4.2.5.Rest of Asia-Pacific

7.4.2.5.1.Rest of Asia-Pacific Specialty PACS market, by type
7.4.2.5.2.Rest of Asia-Pacific Specialty PACS market, By Deployment model
7.4.2.5.3.Rest of Asia-Pacific Specialty PACS market, by end user

7.4.3.Asia-Pacific market size and forecast, by type
7.4.4.Asia-Pacific market size and forecast, By Deployment model
7.4.5.Asia-Pacific market size and forecast, by end user

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country

7.5.2.1.Brazil

7.5.2.1.1.Brazil Specialty PACS market, by type
7.5.2.1.2.Brazil Specialty PACS market, By Deployment model
7.5.2.1.3.Brazil Specialty PACS market, by end user

7.5.2.2.Saudi Arabia

7.5.2.2.1.Saudi Arabia Specialty PACS market, by type
7.5.2.2.2.Saudi Arabia Specialty PACS market, By Deployment model
7.5.2.2.3.Saudi Arabia Specialty PACS market, by end user

7.5.2.3.South Africa

7.5.2.3.1.South Africa Specialty PACS market, by type
7.5.2.3.2.South Africa Specialty PACS market, By Deployment model
7.5.2.3.3.South Africa Specialty PACS market, by end user

7.5.2.4.Rest of LAMEA

7.5.2.4.1.Rest of LAMEA Specialty PACS market, by type
7.5.2.4.2.Rest of LAMEA Specialty PACS market, By Deployment model
7.5.2.4.3.Rest of LAMEA Specialty PACS market, by end user

7.5.3.LAMEA market size and forecast, by type
7.5.4.LAMEA market size and forecast, By Deployment model
7.5.5.LAMEA market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

8.1.Canon Inc. (Canon Medical System Corporation)

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance

8.2.Escalon Medical Corp.

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance

8.3.EyePACS, LLC

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio

8.4.IBM Corporation

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance

8.5.INFINITT Healthcare Co. Ltd.

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Key strategic moves and developments

8.6.Koninklijke Philips N.V.

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance

8.7.McKesson Corporation

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance

8.8.Novarad

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio

8.9.Onex Corporation (Carestream Health)

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance

8.10.Siemens AG

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments


List of Tables

LIST OF TABLES

TABLE 01.SPECIALTY PACS MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 02.SPECIALTY PACS MARKET FOR RADIOLOGY PACS, BY REGION, 2020–2030 ($MILLION)
TABLE 03.SPECIALTY PACS MARKET FOR ORTHOPEDICS PACS, BY REGION, 2020–2030 ($MILLION)
TABLE 04.SPECIALTY PACS MARKET FOR ONCOLOGY PACS, BY REGION, 2020–2030 ($MILLION)
TABLE 05.SPECIALTY PACS MARKET FOR PATHOLOGY PACS, BY REGION, 2020–2030 ($MILLION)
TABLE 06.SPECIALTY PACS MARKET FOR OPHTHALMOLOGY PACS, BY REGION, 2020–2030 ($MILLION)
TABLE 07.SPECIALTY PACS MARKET FOR WOMEN HEALTH PACS, BY REGION, 2020–2030 ($MILLION)
TABLE 08.SPECIALTY PACS MARKET FOR OTHERS, BY REGION, 2020–2030 ($MILLION)
TABLE 09.SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 10.SPECIALTY PACS MARKET FOR ON-PREMISES SPECIALTY PACS, BY REGION, 2020–2030 ($MILLION)
TABLE 11.SPECIALTY PACS FOR CLOUD-BASED SPECIALTY PACS, BY REGION, 2020–2030 ($MILLION)
TABLE 12.SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 13.SPECIALTY PACS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020–2030 ($MILLION)
TABLE 14.SPECIALTY PACS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2020–2030 ($MILLION)
TABLE 15.SPECIALTY PACS MARKET FOR OTHERS, BY REGION, 2020–2030 ($MILLION)
TABLE 16.SPECIALTY PACS MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 17.NORTH AMERICA SPECIALTY PACS MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 18.U.S. SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 19.U.S. SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 20.U.S. SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 21.CANADA SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 22.CANADA SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 23.CANADA SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 24.MEXICO SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 25.MEXICO SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 26.MEXICO SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 27.NORTH AMERICA SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 28.NORTH AMERICA SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 29.NORTH AMERICA SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 30.EUROPE SPECIALTY PACS MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 31.GERMANY SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 32.GERMANY SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 33.GERMANY SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 34.FRANCE SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 35.FRANCE SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 36.FRANCE SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 37.UK SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 38.UK SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 39.UK SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 40.ITALY SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 41.ITALY SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 42.ITALY SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 43.SPAIN SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 44.SPAIN SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 45.SPAIN SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 46.REST OF EUROPE SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 47.REST OF EUROPE SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 48.REST OF EUROPE SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 49.EUROPE SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 50.EUROPE SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 51.EUROPE SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 52.ASIA-PACIFIC SPECIALTY PACS MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 53.JAPAN SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 54.JAPAN SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 55.JAPAN SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 56.CHINA SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 57.CHINA SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 58.CHINA SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 59.AUSTRALIA SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 60.AUSTRALIA SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 61.AUSTRALIA SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 62.INDIA SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 63.INDIA SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 64.INDIA SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 65.SOUTH KOREA SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 66.SOUTH KOREA SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 67.SOUTH KOREA SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 68.REST OF ASIA-PACIFIC SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 69.REST OF ASIA-PACIFIC SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 70.REST OF ASIA-PACIFIC SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 71.ASIA-PACIFIC SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 72.ASIA-PACIFIC SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 73.ASIA-PACIFIC SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 74.LAMEA SPECIALTY PACS MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 75.BRAZIL SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 76.BRAZIL SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 77.BRAZIL SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 78.SAUDI ARABIA SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 79.SAUDI ARABIA SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 80.SAUDI ARABIA SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 81.SOUTH AFRICA SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 82.SOUTH AFRICA SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 83.SOUTH AFRICA SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 84.REST OF LAMEA SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 85.REST OF LAMEA SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 86.REST OF LAMEA SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 87.LAMEA SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 88.LAMEA SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 89.LAMEA SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 90.CANON: COMPANY SNAPSHOT
TABLE 91.CANON: OPERATING SEGMENTS
TABLE 92.CANON: PRODUCT PORTFOLIO
TABLE 93.ESCALON: COMPANY SNAPSHOT
TABLE 94.ESCALON: OERATING SEGMENT
TABLE 95.ESCALON: PRODUCT PORTFOLIO
TABLE 96.EYEPACS: COMPANY SNAPSHOT
TABLE 97.EYEPACS: OPERATING SEGMENTS
TABLE 98.EYEPACS: PRODUCT PORTFOLIO
TABLE 99.IBM: COMPANY SNAPSHOT
TABLE 100.IBM: OPERATING SEGMENTS
TABLE 101.IBM: PRODUCT PORTFOLIO
TABLE 102.INFINITT: COMPANY SNAPSHOT
TABLE 103.INFINITT: OERATING SEGMENT
TABLE 104.INFINITT.: PRODUCT PORTFOLIO
TABLE 105.INFINITT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 106.PHILLIPS: COMPANY SNAPSHOT
TABLE 107.PHILLIPS: OPERATING SEGMENTS
TABLE 108.PHILLIPS: PRODUCT PORTFOLIO
TABLE 109.MCKESSON: COMPANY SNAPSHOT
TABLE 110.MCKESSON: OERATING SEGMENT
TABLE 111.MCKESSON: PRODUCT PORTFOLIO
TABLE 112.NOVARAD: COMPANY SNAPSHOT
TABLE 113.NOVARAD: OPERATING SEGMENTS
TABLE 114.NOVARAD: PRODUCT PORTFOLIO
TABLE 115.ONEX: COMPANY SNAPSHOT
TABLE 116.ONEX: OPERATING SEGMENTS
TABLE 117.ONEX: PRODUCT PORTFOLIO
TABLE 118.SIEMENS: COMPANY SNAPSHOT
TABLE 119.SIEMENS: OPERATING SEGMENTS
TABLE 120.SIEMENS: PRODUCT PORTFOLIO
TABLE 121.SIEMENS: KEY STRATEGIC MOVES AND DEVELOPMENTS


List of Figures

LIST OF FIGURES

FIGURE 01.SPECIALTY PACS MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 04.MODERATE BARGAINING POWER OF BUYERS
FIGURE 05.MODERATE THREAT OF SUBSTITUTES
FIGURE 06.MODERATE THREAT OF NEW ENTRANTS
FIGURE 07.HIGH INTENSITY OF RIVALRY
FIGURE 08.TOP PLAYER POSITIONING, 2020
FIGURE 09.IMPACT ANALYSIS
FIGURE 10.COMPARATIVE ANALYSIS OF SPECIALTY PACS MARKET FOR RADIOLOGY PACS, BY COUNTRY, 2020–2030 ($MILLION)
FIGURE 11.COMPARATIVE ANALYSIS OF SPECIALTY PACS MARKET FOR ORTHOPEDICS PACS, BY COUNTRY, 2020–2030 ($MILLION)
FIGURE 12.COMPARATIVE ANALYSIS OF SPECIALTY PACS MARKET FOR ONCOLOGY PACS, BY COUNTRY, 2020–2030 ($MILLION)
FIGURE 13.COMPARATIVE ANALYSIS OF SPECIALTY PACS MARKET FOR PATHOLOGY PACS, BY COUNTRY, 2020–2030 ($MILLION)
FIGURE 14.COMPARATIVE ANALYSIS OF SPECIALTY PACS MARKET FOR OPHTHALMOLOGY PACS, BY COUNTRY, 2020–2030 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF SPECIALTY PACS MARKET FOR WOMEN HEALTH PACS, BY COUNTRY, 2020–2030 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF SPECIALTY PACS MARKET FOR OTHERS, BY COUNTRY, 2020–2030 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF SPECIALTY PACS MARKET FOR ON-PREMISES SPECIALTY PACS, BY COUNTRY, 2020–2030 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF SPECIALTY PACS FOR CLOUD-BASED SPECIALTY PACS SEGMENT, BY COUNTRY, 2020–2030 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF SPECIALTY PACS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020–2030 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF SPECIALTY PACS MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2020–2030 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF SPECIALTY PACS MARKET FOR OTHERS, BY COUNTRY, 2020–2030 ($MILLION)
FIGURE 22.CANON: NET SALES, 2018–2020 ($MILLION)
FIGURE 23.CANON: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 24.CANON: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 25.ESCALON: NET SALES, 2018–2020 ($MILLION)
FIGURE 26.ESCALON: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 27.IBM: NET SALES, 2018–2020 ($MILLION)
FIGURE 28.IBM: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 29.IBM: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 30.PHILLIPS: NET SALES, 2018–2020 ($MILLION)
FIGURE 31.PHILLIPS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 32.PHILLIPS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 33.MCKESSON: NET SALES, 2019–2021 ($MILLION)
FIGURE 34.MCKESSON: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 35.ONEX: NET SALES, 2018–2020 ($MILLION)
FIGURE 36.ONEX: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 37.SIEMENS: NET SALES, 2019–2021 ($MILLION)
FIGURE 38.SIEMENS: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 39.SIEMENS: REVENUE SHARE BY SEGMENT, 2021 (%)